Search

Oluwatosin A. Ogunbiyi

Examiner (ID: 17664, Phone: (571)272-9939 , Office: P/1645 )

Most Active Art Unit
1645
Art Unit(s)
1645
Total Applications
1148
Issued Applications
603
Pending Applications
160
Abandoned Applications
405

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 20484972 [patent_doc_number] => 20260021170 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2026-01-22 [patent_title] => TREATMENT OF PAIN [patent_app_type] => utility [patent_app_number] => 19/342035 [patent_app_country] => US [patent_app_date] => 2025-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 60493 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -5 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19342035 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/342035
TREATMENT OF PAIN Sep 25, 2025 Abandoned
Array ( [id] => 20393218 [patent_doc_number] => 20250368693 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-12-04 [patent_title] => PEPTIDE COMPOSITION AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 19/008184 [patent_app_country] => US [patent_app_date] => 2025-01-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7669 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19008184 [rel_patent_id] =>[rel_patent_doc_number] =>)
19/008184
PEPTIDE COMPOSITION AND USES THEREOF Jan 1, 2025 Pending
Array ( [id] => 20039285 [patent_doc_number] => 20250177507 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-06-05 [patent_title] => Multivalent Vaccine Compositions [patent_app_type] => utility [patent_app_number] => 18/967715 [patent_app_country] => US [patent_app_date] => 2024-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 0 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18967715 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/967715
Multivalent Vaccine Compositions Dec 3, 2024 Pending
Array ( [id] => 20356233 [patent_doc_number] => 12472212 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-11-18 [patent_title] => None [patent_app_type] => utility [patent_app_number] => 18/938752 [patent_app_country] => US [patent_app_date] => 2024-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 0 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 154 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18938752 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/938752
None Nov 5, 2024 Issued
Array ( [id] => 19798986 [patent_doc_number] => 20250064911 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-27 [patent_title] => BACILLUS CALMETTE-GUERIN (BCG) AND ANTIGEN PRESENTING CELLS FOR TREATMENT OF BLADDER CANCER [patent_app_type] => utility [patent_app_number] => 18/933925 [patent_app_country] => US [patent_app_date] => 2024-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13058 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18933925 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/933925
BACILLUS CALMETTE-GUERIN (BCG) AND ANTIGEN PRESENTING CELLS FOR TREATMENT OF BLADDER CANCER Oct 30, 2024 Pending
Array ( [id] => 19996773 [patent_doc_number] => 20250134995 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-05-01 [patent_title] => SAPONIN-BASED ADJUVANTS AND METHODS OF CHARACTERIZING SAME [patent_app_type] => utility [patent_app_number] => 18/927547 [patent_app_country] => US [patent_app_date] => 2024-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7370 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18927547 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/927547
SAPONIN-BASED ADJUVANTS AND METHODS OF CHARACTERIZING SAME Oct 24, 2024 Pending
Array ( [id] => 19754761 [patent_doc_number] => 20250043326 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-06 [patent_title] => NEUROTRANSMITTER TRANSPORT IN PROBIOTICS [patent_app_type] => utility [patent_app_number] => 18/919141 [patent_app_country] => US [patent_app_date] => 2024-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13746 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -1 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18919141 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/919141
NEUROTRANSMITTER TRANSPORT IN PROBIOTICS Oct 16, 2024 Pending
Array ( [id] => 19860643 [patent_doc_number] => 20250099429 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-03-27 [patent_title] => COMPOSITIONS AND METHODS FOR TREATMENT OF VAGINAL INFECTIONS [patent_app_type] => utility [patent_app_number] => 18/907677 [patent_app_country] => US [patent_app_date] => 2024-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11657 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18907677 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/907677
COMPOSITIONS AND METHODS FOR TREATMENT OF VAGINAL INFECTIONS Oct 6, 2024 Pending
Array ( [id] => 19909264 [patent_doc_number] => 12285450 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-04-29 [patent_title] => None [patent_app_type] => utility [patent_app_number] => 18/895456 [patent_app_country] => US [patent_app_date] => 2024-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 3505 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18895456 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/895456
None Sep 24, 2024 Issued
Array ( [id] => 19768480 [patent_doc_number] => 20250049906 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-13 [patent_title] => IMMUNOGENIC COMPOSITIONS [patent_app_type] => utility [patent_app_number] => 18/894961 [patent_app_country] => US [patent_app_date] => 2024-09-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17415 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18894961 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/894961
IMMUNOGENIC COMPOSITIONS Sep 23, 2024 Pending
Array ( [id] => 19815127 [patent_doc_number] => 20250073334 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-03-06 [patent_title] => INJECTABLE HYDROGEL FOR SUSTAINED CO-DELIVERY OF AN ANTIGEN AND AN ADJUVANT, AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 18/826093 [patent_app_country] => US [patent_app_date] => 2024-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17823 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18826093 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/826093
INJECTABLE HYDROGEL FOR SUSTAINED CO-DELIVERY OF AN ANTIGEN AND AN ADJUVANT, AND USES THEREOF Sep 4, 2024 Pending
Array ( [id] => 19960315 [patent_doc_number] => 12329787 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2025-06-17 [patent_title] => Microbial compositions for the treatment of skin diseases [patent_app_type] => utility [patent_app_number] => 18/825396 [patent_app_country] => US [patent_app_date] => 2024-09-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 27 [patent_no_of_words] => 28634 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18825396 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/825396
Microbial compositions for the treatment of skin diseases Sep 4, 2024 Issued
Array ( [id] => 19798987 [patent_doc_number] => 20250064912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-27 [patent_title] => VACCINES FOR NEISSERIA GONORRHOEAE [patent_app_type] => utility [patent_app_number] => 18/824050 [patent_app_country] => US [patent_app_date] => 2024-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9098 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -14 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18824050 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/824050
VACCINES FOR NEISSERIA GONORRHOEAE Sep 3, 2024 Pending
Array ( [id] => 19641388 [patent_doc_number] => 20240415908 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-19 [patent_title] => ENTERIC AEROBIZATION THERAPY [patent_app_type] => utility [patent_app_number] => 18/821883 [patent_app_country] => US [patent_app_date] => 2024-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22854 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -18 [patent_words_short_claim] => 140 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18821883 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/821883
Enteric aerobization therapy Aug 29, 2024 Issued
Array ( [id] => 19743998 [patent_doc_number] => 20250032563 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-01-30 [patent_title] => METHODS FOR THE TREATMENT OF INFLAMMATION AND INFLAMMATORY CONDITIONS [patent_app_type] => utility [patent_app_number] => 18/813998 [patent_app_country] => US [patent_app_date] => 2024-08-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10005 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18813998 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/813998
METHODS FOR THE TREATMENT OF INFLAMMATION AND INFLAMMATORY CONDITIONS Aug 22, 2024 Pending
Array ( [id] => 20098987 [patent_doc_number] => 20250228923 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-07-17 [patent_title] => COMBINED VACCINE AGAINST MYCOBACTERIUM TUBERCULOSIS [patent_app_type] => utility [patent_app_number] => 18/787546 [patent_app_country] => US [patent_app_date] => 2024-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 50218 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18787546 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/787546
COMBINED VACCINE AGAINST MYCOBACTERIUM TUBERCULOSIS Jul 28, 2024 Pending
18/730619 CHIMERIC POLYPEPTIDES Jul 18, 2024 Pending
Array ( [id] => 19770054 [patent_doc_number] => 20250051480 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2025-02-13 [patent_title] => SUBSTANCES AND METHODS FOR THE USE IN PREVENTION AND/OR TREATMENT IN HUNTINGTON'S DISEASE [patent_app_type] => utility [patent_app_number] => 18/768852 [patent_app_country] => US [patent_app_date] => 2024-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19812 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -11 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18768852 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/768852
SUBSTANCES AND METHODS FOR THE USE IN PREVENTION AND/OR TREATMENT IN HUNTINGTON'S DISEASE Jul 9, 2024 Pending
Array ( [id] => 19657013 [patent_doc_number] => 20240424078 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-26 [patent_title] => GROUP B STREPTOCOCCUS CAPSULAR POLYSACCHARIDE VACCINE AND METHODS OF USE [patent_app_type] => utility [patent_app_number] => 18/761709 [patent_app_country] => US [patent_app_date] => 2024-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27416 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -7 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18761709 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/761709
GROUP B STREPTOCOCCUS CAPSULAR POLYSACCHARIDE VACCINE AND METHODS OF USE Jul 1, 2024 Abandoned
Array ( [id] => 19657010 [patent_doc_number] => 20240424075 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2024-12-26 [patent_title] => IMMUNOREACTIVE PEPTIDES [patent_app_type] => utility [patent_app_number] => 18/754918 [patent_app_country] => US [patent_app_date] => 2024-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15113 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -28 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18754918 [rel_patent_id] =>[rel_patent_doc_number] =>)
18/754918
Immunoreactive peptides Jun 25, 2024 Issued
Menu